Living with pulmonary hypertension: quality not just quantity

Condliffe R.

Source: Eur Respir J 2011; 38: 512-513
Journal Issue: September

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Condliffe R.. Living with pulmonary hypertension: quality not just quantity. Eur Respir J 2011; 38: 512-513

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015



Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
Source: Eur Respir J 2014; 43: 1106-1113
Year: 2014



EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR
Source: Eur Respir J, 57 (2) 2000414; 10.1183/13993003.00414-2020
Year: 2021



Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006



Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Benchmark analysis of quality of life in patients with bronchial asthma complicated by different degree of remodeling of right ventricle of the heart
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013

Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013

Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011



Correlations between clinical variables and quality of life in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005

The influence of psycho-social factors in the evolution of pulmonary hypertension patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Impact of insomnia on exercise capacity and quality of life in patients with pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011

Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009